The assessment of the application concerning the modification of the essential nutritional characteristics linked to the DCAD as well as the application concerning the addition to the list of intended uses of glycosylated 1,25-dihydroxycholecalciferol from Solanum glaucophyllum extract applied as in the animal studies evaluated shows that the specific composition of the two feeds concerned fulfil the particular intended nutritional purpose and that they do not have adverse effects on animal health, human health, the environment or animal welfare.
Recital 5, Regulation (EU) 2024/2899
In force